When was PharmaCielo founded?

PharmaCielo was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is PharmaCielo located?

PharmaCielo is headquartered in Toronto, Canada.

How many employees does PharmaCielo have?

As of Aug 31, 2026, the latest employee count at PharmaCielo is 107.

Is PharmaCielo a funded company?

PharmaCielo is a funded company, having raised a total of $16.4M across 10 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 12, 2015.

When was the latest funding round of PharmaCielo?

PharmaCielo's latest funding was a $***** Post IPO round on Nov 03, 2020, with participation from 0 investor. Its primary sector is Crop Tech. In Canada, the Crop Tech sector has seen $40M in funding in 2026 to date.

Where does PharmaCielo rank among its competitors?

PharmaCielo ranks 4th amongst 229 active competitors, of which 21 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Cannara Biotech, which secured $4.61M in Feb, 2026.

Who are the top competitors of PharmaCielo?

PharmaCielo's top competitors include Organigram, Canopy Growth and Cannara Biotech. Among them, Cannara Biotech secured the most recent funding round in February, 2026.

PharmaCielo - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of pharmaceutical quality cannabis flower and extracts for medicinal applications. The company focuses on consistent, safe, and reliable production meeting high standards. It utilizes tissue culture labs for preserving proprietary varieties. The company produces consistent, high-quality extracts, both psychoactive and non-psychoactive. It offers CBD isolate refined to remove THC and impurities.

Website: www.pharmacielo.com/
Social
Email ID: *****@pharmacielo.com
Phone Number: +1 **********

Key Metrics

Founded Year

2014

Location

Toronto, Canada

Stage

Public

Total Funding

$16.4M in 10 rounds

Latest Funding Round

Post IPO, Nov 03, 2020, $*****

Investors

Stifel & 2 more

Ranked

4^th among 229 active competitors

Employee Count

107 as on Aug 31, 2026

Investment & Acquisitions

Creso Pharma & 1 more

Similar Companies

Organigram & 243 more

Exit Details

Public

View PharmaCielo's full profile

PharmaCielo got listed on Feb 02, 2018.

Click here to take a look at PharmaCielo's IPO in detail

PharmaCielo has raised a total funding of $16.4M over 10 rounds. Its first funding round was on May 12, 2015. PharmaCielo has 3 institutional investors.

Here is the list of recent funding rounds of PharmaCielo:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 03, 2020	6751654	Post IPO	7974789	5001893	8011477	3286595
Apr 01, 2020	3038528	Post IPO	9479695	4292759	8757897	8185021
Feb 11, 2019	1144528	Post IPO	8164645	3257000	9807363	8160634

Access funding benchmarks and valuations. Sign up today!

View details of PharmaCielo's funding rounds and investors

PharmaCielo's employee count trend

PharmaCielo has 107 employees as of Aug 26. Here is PharmaCielo's employee count trend over the years:

Uncover PharmaCielo's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PharmaCielo include Organigram, Canopy Growth and Cannara Biotech. Here is the list of Top 10 competitors of PharmaCielo, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Organigram 2013, Moncton (Canada), Public	Global cannabis leader driving innovation, operational excellence, and shaping the industry	-	BMO, British American Tobacco & 4 others	66/100
2nd	Canopy Growth 2013, Smiths Falls (Canada), Public	Global cannabis company dedicated to improving lives through cannabis products	-	Stifel, TMX Group & 9 others	66/100
3rd	Cannara Biotech 2018, Montreal (Canada), Public	Producer of premium‐grade cannabis and cannabis‐derivative products	$17.7M	FSD Pharma, Canadian Imperial Bank of Commerce ... & 2 others	64/100
4th	PharmaCielo 2014, Toronto (Canada), Public	Provider of pharmaceutical quality cannabis flower and extracts for medicinal applications	$16.4M	Stifel, Echelon & 1 others	59/100
5th	iAnthus 2014, New York City (United States), Public	Cultivator and processor of cannabis products	$175K	Senvest Capital, Gotham Green Partners	58/100
6th	C21 Investments 1987, Vancouver (Canada), Acquired	Vertically integrated cannabis corporation cultivating, processing, manufacturing, and distributing quality consumer products	-	MGI Securities, Iavaleursmobilieres & 2 others	58/100
7th	Rubicon Organics 2014, Vancouver (Canada), Public	Premium cannabis brand builder delivering elevated experiences through quality and innovation	$10.8M	-	56/100
8th	Planet 13 Holdings 2015, Las Vegas (United States), Public	Vertically integrated cannabis company offering a range of annabis products	$11.4M	Canaccord Genuity Group, Beacon Securities	54/100
9th	Maricann 2013, Burlington (Canada), Acquired	Provider of curated lifestyle and medical cannabis products in various forms	$7.65M	-	54/100
10th	Vireo Health 2004, Minneapolis (United States), Late Stage	Chains providing cannabis-based products through dispensaries and third-party retail locations	-	Cannabis Growth Opportunity Corporation, Merida Capital Partners ... Read more	50/100